rss Posted December 19, 2018 Report Share Posted December 19, 2018 Complete Decongestive Therapy Is an Option for the Treatment of Rosacea Lymphedema (Morbihan Disease): Two Cases. Phys Ther. 2018 Dec 18;: Authors: Kutlay S, Ozdemir EC, Pala Z, Ozen S, Sanli H Abstract Background and Purpose: Morbihan disease, also known as rosacea lymphedema, is a rare persistent form of lymphedema that is associated with the disease of rosacea. Even though acne rosacea responds well to standard medical treatment, the lymphedema component of the disease is resistant to both medical and surgical therapy. Complete decongestive therapy (CDT) may be considered as a conservative alternative option for treatment of rosacea lymphedema. To date, there is no report on the use of CDT in treating facial lymphedema secondary to acne rosacea. Case Description: Here, we present two cases of women with a diagnosis of Morbihan disease and chronic facial lymphedema which remained resistant to drug treatment for many years before CDT was offered. The treatment program included 4 components: manual lymphatic drainage (MLD), compression bandaging, exercises to enhance lymphatic drainage, and patient education. Outcomes: Following 10 to 15 sessions of CDT, the first patient's facial edema had almost completely resolved, and she remained edema-free one month after treatment. The second patient's response to treatment was assessed as moderate. Discussion: To the best of our knowledge, these two cases of Morbihan disease treated with CDT are the first of their kind to be presented in the literature. As the treatment options for Morbihan disease remain inadequate, we believe that CDT should be considered as a treatment option in those patients who do not benefit from or refuse drug treatment, before moving on to more invasive procedures. Prospective studies should be designed to demonstrate the efficacy of CDT and provide management details. PMID: 30561675 [PubMed - as supplied by publisher] {url} = URL to article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now